P/E ratio for MiMedx Group (MDXG)
P/E ratio as of May 2024 (TTM): -321
According to MiMedx Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -321.293. At the end of 2022 the company had a P/E ratio of -8.42.
P/E ratio history for MiMedx Group from 2008 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -8.42 | -79.08% |
| 2021 | -40.3 | 241.47% |
| 2020 | -11.8 | -64.22% |
| 2019 | -33.0 | 418.61% |
| 2018 | -6.35 | -130.74% |
| 2017 | 20.7 | -99.14% |
| 2016 | > 1000 | 7090.65% |
| 2015 | 33.5 | -83.66% |
| 2014 | 205 | -201.13% |
| 2013 | -202 | 374.52% |
| 2012 | -42.7 | 390.86% |
| 2011 | -8.69 | 22.34% |
| 2010 | -7.11 | 162.8% |
| 2009 | -2.70 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | 31.5 | -109.80% | 🇮🇪 Ireland |
 Teleflex TFX | 25.4 | -107.91% | 🇺🇸 USA |
 Steris STE | 188 | -158.38% | 🇮🇪 Ireland |
 NuVasive NUVA | 73.6 | -122.91% | 🇺🇸 USA |
 Hill-Rom HRC | N/A | N/A | 🇺🇸 USA |
 CryoLife CRY | N/A | N/A | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.